Related Experiment Video

Updated: Feb 23, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.5K

miR-206 enhances nasopharyngeal carcinoma radiosensitivity by targeting IGF1

Tian Wang1, Xin-Min Dong1, Fu-Lin Zhang2

  • 1Department of Oncology, ZhuJiang Hospital of Southern Medical University, Guangzhou, China.

The Kaohsiung Journal of Medical Sciences
|September 4, 2017
PubMed

Insights

MicroRNA-206 (miR-206) is down-regulated in radioresistant nasopharyngeal carcinoma (NPC). Restoring miR-206 sensitizes NPC cells to radiation by targeting IGF1 and inhibiting the PI3K/AKT pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Nasopharyngeal carcinoma (NPC) exhibits significant radioresistance, hindering effective treatment.
  • The molecular mechanisms driving NPC radioresistance are not fully elucidated.
  • MicroRNAs (miRNAs) are emerging as critical regulators in cancer progression and treatment response.

Purpose of the Study:

  • To investigate the role of miR-206 in the radioresistance of nasopharyngeal carcinoma.
  • To elucidate the molecular mechanism by which miR-206 influences NPC radiosensitivity.

Main Methods:

  • Quantitative real-time PCR to assess miR-206 expression levels in NPC cells.
  • Cell viability assays and colony formation assays to evaluate radiosensitivity after miR-206 manipulation.
  • Western blotting to analyze protein expression levels of target genes and signaling pathways.
  • Luciferase reporter assays to confirm direct targeting of IGF1 by miR-206.

Main Results:

  • miR-206 expression was significantly downregulated in radioresistant NPC cells (CNE2-IR) compared to sensitive cells (CNE2).
  • Overexpression of miR-206 in CNE2-IR cells restored sensitivity to irradiation.
  • Inhibition of miR-206 in CNE2 cells decreased their radiosensitivity.
  • miR-206 directly targets Insulin-like Growth Factor 1 (IGF1) and suppresses the PI3K/AKT signaling pathway.

Conclusions:

  • miR-206 acts as a tumor suppressor in NPC radioresistance.
  • miR-206 sensitizes NPC cells to radiotherapy by targeting IGF1 and inhibiting the PI3K/AKT pathway.
  • miR-206 represents a potential therapeutic target for overcoming radioresistance in nasopharyngeal carcinoma.
Keywords:
IGF1Nasopharyngeal carcinomaPI3K/AKT pathwayRadioresistancemiR-206

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K